Dr. Xiaodong Wang is the Founding Director & Architect of a 700-person team at the National Institute of Biological Sciences (NIBS) in Beijing. In 2010 he founded BeiGene (NASDAQ: BGNE), a globally focused biopharmaceutical company dedicated to the discovery and development of innovative treatments for cancer. A Howard Hughes Medical Institute Investigator, Dr. Wang served as the George L. MacGregor Distinguished Chair in Biomedical Sciences at the University of Texas Southwestern Medical Center from 1997 to 2010 and as Professor in Biomedical Sciences from 2001 to 2010. He is a member of National Academy of Sciences in the United States and a Foreign Associate of the Chinese Academy of Sciences. Dr. Wang previously founded Joyant Pharmaceuticals, a US-based venture capital-backed oncology biotech, in 2004.
王曉東: 美籍華人科學家,美國國家科學院院士,2013年新當選中國科學院外籍院士,美國德克薩斯大學西南醫學中心教授,前Joyant Pharmaceuticals美國腫瘤生物技術公司創始人,百濟神州(NASDAQ: BGNE)創始人、首席科學家,北京生命科學研究所所長。
7:30PM, Tuesday, December 19th, 2017
2017年12月19日周二,晚上7:30
Doors Open at 7:00 pm
晚上7:00開始入場
Dalio Auditorium, Level B2, Schwarzman College, Tsinghua University
清華大學蘇世民書院地下二層,達理禮堂
This event is open to Tsinghua students, faculty, and staff.
Please present valid Tsinghua ID Card to access Schwarzman College.
Guests will be admitted until all seating is full.
This lecture will be given in English.
請參會觀眾遵守活動秩序,憑清華有效證件入場。
因座位有限,請提早前往,坐滿即止。
歡迎清華大學各院系師生參加。
講座語言為英文 。
清華大學蘇世民書院秉承“立足中國、面向世界”的原則,整合全球一流教育資源,依托清華大學綜合實力,積極探索國際人才培養和人文交流新模式。作為清華大學新百年發展的重點舉措,項目自創建伊始即得到全球各界領導者的關注和支持。中國國家主席習近平和美國時任總統奧巴馬分別兩次發來賀信。項目每年在全球招收至多200名學生在蘇世民書院進行全英文的碩士課程學習,每名學生都獲得項目提供的綜合獎學金。了解更多招生及書院信息,請登陸網站www.xyszsc.cn,并關注微信公眾平臺@清華大學蘇世民書院,以及新浪微博 @清華大學蘇世民學者項目。